J3245 — Tildrakizumab-asmn 100 Mg/ml Subcutaneous Syringe
$22,793
All-payer median here
$25,864
Cash / self-pay here
9
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.